Integer Holdings Corporation
HealthcareNYSE:ITGR · New York Stock Exchange
-$1.12 today
Vol 0.14M · Avg 0.61M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
5.9%
avg 6.3%
ROIC
5.4%
avg 4.5%
ROA
3.0%
avg 3.0%
Analysis
ROE is currently the strongest return metric at 5.9% versus its period average of 6.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Payman Khales | Chief Executive Officer, President & Director | $1.06M | — | 56 | $51,816.00 | 0.15% |
Andrew Senn | President of Cardio & Vascular | $907,965.00 | — | 44 | $16,260.00 | 0.05% |
Diron Smith | Executive Vice President & Chief Financial Officer | $844,106.00 | — | 52 | $12,918.83 | 0.04% |
John Harris | Executive Vice President of Global Operations & Manufacturing Strategy | $822,685.00 | — | 66 | $0.00 | <0.01% |
Kirk K. Thor | Executive Vice President & Chief Human Resources Officer | $791,644.00 | — | 62 | $3,556.00 | 0.01% |
Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation | $742,776.00 | — | 52 | $4,859.00 | 0.01% |
Lindsay Krause Blackwood | Senior Vice President, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | $619,041.00 | — | 49 | $3,556.00 | 0.01% |
Tom Thomas | Vice President, Corporate Controller & Principal Accounting Officer | — | — | 55 | $666.00 | <0.01% |
Carol Russell | Vice President & Chief Information Officer | — | — | — | — | — |
Kristen Marie Stewart | Director of Investor Relations | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
4
$500,254.42
Sells
2
$132,137.60
Net Sentiment
+$368,116.82
Net buying
Most Active
Thomas Tommy P
2 transactions
Analysis
Insiders reported 4 buys worth $500,254.42 and 2 sells worth $132,137.60 over the last 12 months. That adds up to net buying of $368,116.82. Thomas Tommy P was the most active insider with 2 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A4 analysts |
| Revenue | N/A | N/A | +7.4% | +7.5% (14yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | -42.4% | +24.3% (14yr)2 analysts |
Analysis
Recent growth has been strongest in Revenue at +7.4% over three years. Forward estimates point to EBIT at +24.3% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
LivaNova PLC
NASDAQ:LIVN
$4.36B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.60B
Haemonetics Corporation
NYSE:HAE
$3.55B
Premier, Inc.
PINC
$2.34B
UFP Technologies, Inc.
NASDAQ:UFPT
$1.82B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.41B
Inspire Medical Systems, Inc.
NYSE:INSP
$1.23B
Artivion, Inc.
NYSE:AORT
$975.72M
Who manages ITGR?
Integer Holdings Corporation (ITGR) lists 10 active executives. The top listed executive is Andrew Senn, President of Cardio & Vascular.
Are ITGR insiders buying or selling?
Recent insider activity shows net selling of $59.83M.
Explore More
Continue the stock analysis
Jump to another research area for this company.